StockData
Pharming Group N.V. logo

Pharming Group N.V. (PHAR) income statement

PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 2, 2026Score 8/30
$12.17−0.31 (-2.51%)

Close on Nov 19, 2026Market cap $853.95MP/E 304.3Yield –

See a number that looks wrong?